M. Stein

Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.

M. Meissner, R. Kaufmann, J. Gille, 2009, Cancer research.

Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms.

M. Meissner, R. Kaufmann, W. Holtmeier, 2008, The Journal of investigative dermatology.

Fluid shear stress‐induced transcriptional activation of the vascular endothelial growth factor receptor‐2 gene requires Sp1‐dependent DNA binding

S. Dimmeler, C. Urbich, R. Kaufmann, 2003, FEBS letters.

Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor‐2 expression by suppressing Sp1‐dependent DNA binding in human endothelial cells

M. Meissner, R. Kaufmann, J. Gille, 2009, Experimental dermatology.

PPAR&agr; Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation

C. Urbich, B. Staels, M. Meissner, 2004, Circulation research.

Repressing Sp 1-Dependent DNA Binding and Transactivation Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by α PPAR

C. Urbich, B. Staels, M. Meissner, 2004 .

Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor‐2 expression by suppressing Sp1‐dependent DNA binding in human endothelial cells

M. Meissner, R. Kaufmann, J. Gille, 2009, Experimental dermatology.